Ceapro (CRPOF) Stock Price, News & Analysis

Company Overview

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Key Stats

• Today's Range: $0.17 to $0.17
• 50-Day Range: $0.17 to $0.17
• 52-Week Range: $0.11 to $0.40
• Volume: N/A
• Average Volume: 15,466 shs
• Market Capitalization: $13.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CRPOF Stock Analysis - Frequently Asked Questions

How have CRPOF shares performed this year?

Ceapro's stock was trading at $0.17 at the beginning of 2025. Since then, CRPOF shares have increased by 0.0% and is now trading at $0.17.

How do I buy shares of Ceapro?

Shares of CRPOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CRPOF
• CIK: N/A
• Web: www.ceapro.com
• Phone: (780) 421-4555
• Fax: 780-421-1320
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.49 million
• Net Margins: -69.60%
• Pretax Margin: -31.44%
• Return on Equity: -20.30%
• Return on Assets: -18.07%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 11.00
• Quick Ratio: 7.72

Sales & Book Value

• Annual Sales: $7.14 million
• Price / Sales: 1.86
• Cash Flow: $0.06 per share
• Price / Cash Flow: 2.74
• Book Value: $0.32 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 78,293,000
• Free Float: N/A
• Market Cap: $13.31 million
• Optionable: Not Optionable
• Beta: 1.47